| Name | Title | Contact Details |
|---|
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
2023 Earthshot Prize Finalist on a mission to protect the planet from the cost of clothing. At Circ, weve created a technology system that returns clothes to the raw materials from which they were made. Again and again. Brand partners like Patagonia, Marubeni, and Fashion For Good are joining us in our goal of turning wasteful fashion lines into renewable fashion circles. By 2030, we expect to have recycled 10 billion garments, represent 10% of the global apparel market, and to have saved more than 100 million trees. As our ecology and economy grow evermore entwined, it is clear to us that the world already has all the clothing it needs to create all the clothing it will ever need. Join us in threading together the future of circular fashion and eliminating our collective fashion footprint.
HPI redefines what is possible with self-funded health plans. As a third-party administrator, we partner with health plan brokers and employers to provide innovative self-funding strategies and customized plans tailored to each clients needs and population. Our solutions give employers greater cost transparency and control, while elevating the member experience.
DRAXXON is a global manufacturer of specialty vehicle solutions, integrating cutting edge technology into vans, SUVS, trailers, and ruggedized Pelican case configurations.